We have followed, at 3, 6, 12, 24 months after the onset of therapy with LTG in add-on, 584 patients with refractory Generalized and Partial Epilepsy. 389 patients reached two years of therapy. The outcomes show that efficacy was significantly preserved in all of the various syndromes of Epilepsy.
Studio triveneto sulla Lamotrigina: Mantenimento ed efficacia terapeutica nell'arco di due anni
DE MARCO, PASQUALE;BERGONZI, Paolo;COSTA, PIETRO;CRISTOFORI, Guido;GIGLI, Gian Luigi;LUCCI, Bruno;MARINIG, Roberto;PANICO, ANNA CLARA;PAULETTO, GIADA;PRIVATO, Fiorenza;SERENA, MARINA;TOLDO, MASSIMILIANO;
2002-01-01
Abstract
We have followed, at 3, 6, 12, 24 months after the onset of therapy with LTG in add-on, 584 patients with refractory Generalized and Partial Epilepsy. 389 patients reached two years of therapy. The outcomes show that efficacy was significantly preserved in all of the various syndromes of Epilepsy.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
